KAHVECI, Ali Murat; TAHAN, Veysel. Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies. Turkish Journal of Gastroenterology, [S. l.], v. 27, n. 1, p. 89–90, 2016. DOI: 10.5152/tjg.2015.150012. Disponível em: https://www.turkjgastroenterol.org/index.php/tjg/article/view/2845. Acesso em: 1 jan. 2026.